| Year |
Citation |
Score |
| 2022 |
Wilkerson JL, Alberti LB, Thakur GA, Makriyannis A, Milligan ED. Peripherally administered cannabinoid receptor 2 (CBR) agonists lose anti-allodynic effects in TRPV1 knockout mice, while intrathecal administration leads to anti-allodynia and reduced GFAP, CCL2 and TRPV1 expression in the dorsal spinal cord and DRG. Brain Research. 1774: 147721. PMID 34774500 DOI: 10.1016/j.brainres.2021.147721 |
0.699 |
|
| 2021 |
Bilbrey JA, Ortiz YT, Felix JS, McMahon LR, Wilkerson JL. Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement. Psychopharmacology. PMID 34846548 DOI: 10.1007/s00213-021-06031-2 |
0.364 |
|
| 2021 |
Wilkerson JL, Felix JS, Bilbrey JA, McCurdy CR, McMahon LR. Characterization of a mouse neuropathic pain model caused by the highly active antiviral therapy (HAART) Stavudine. Pharmacological Reports : Pr. PMID 33860918 DOI: 10.1007/s43440-021-00262-y |
0.305 |
|
| 2020 |
Wilkerson JL, Alberti LB, Kerwin AA, Ledent CA, Thakur GA, Makriyannis A, Milligan ED. Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain. Brain and Behavior. e01850. PMID 32977358 DOI: 10.1002/brb3.1850 |
0.709 |
|
| 2020 |
Wilkerson JL, Jiang J, Felix JS, Bray JK, da Silva L, Gharaibeh RZ, McMahon LR, Schmittgen TD. Alterations in mouse spinal cord and sciatic nerve microRNAs after the chronic constriction injury (CCI) model of neuropathic pain. Neuroscience Letters. 135029. PMID 32380144 DOI: 10.1016/J.Neulet.2020.135029 |
0.348 |
|
| 2018 |
Sim-Selley LJ, Wilkerson JL, Burston JJ, Hauser KF, McLane V, Welch SP, Lichtman AH, Selley DE. Differential Tolerance to FTY720-induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of S1P Receptor Adaptation. The Journal of Pharmacology and Experimental Therapeutics. PMID 29945931 DOI: 10.1124/Jpet.118.248260 |
0.671 |
|
| 2018 |
Curry Z, Wilkerson J, Bagdas D, Kyte S, Patel N, Donvito G, Mustafa MA, Poklis J, Niphakis M, Hsu KL, Cravatt BF, Gewirtz DA, Damaj MI, Lichtman AH. Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy. The Journal of Pharmacology and Experimental Therapeutics. PMID 29540562 DOI: 10.1124/Jpet.117.245704 |
0.593 |
|
| 2018 |
Wilkerson JL, Curry ZA, Kinlow PD, Mason BL, Hsu KL, van der Stelt M, Cravatt BF, Lichtman AH. Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. Pain. PMID 29528965 DOI: 10.1097/J.Pain.0000000000001199 |
0.641 |
|
| 2017 |
Wilkerson JL, Donvito G, Grim TW, Abdullah RA, Ogasawara D, Cravatt BF, Lichtman AH. Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model. The Journal of Pharmacology and Experimental Therapeutics. PMID 28970359 DOI: 10.1124/Jpet.117.243808 |
0.497 |
|
| 2017 |
Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG, Lichtman AH. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28857069 DOI: 10.1038/Npp.2017.204 |
0.759 |
|
| 2016 |
Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R, Maldonado RL, Cravatt BF, Lichtman AH. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Neuropharmacology. PMID 27890602 DOI: 10.1016/J.Neuropharm.2016.11.015 |
0.746 |
|
| 2016 |
Donvito G, Wilkerson JL, Damaj MI, Lichtman AH. Palmitoylethanolamide reverses paclitaxel-induced allodynia in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27608657 DOI: 10.1124/Jpet.116.236182 |
0.571 |
|
| 2016 |
Bagdas D, Wilkerson JL, Kulkarni A, Toma W, AlSharari S, Gul Z, Lichtman AH, Papke RL, Thakur GA, Imad Damaj M. The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain. British Journal of Pharmacology. PMID 27243753 DOI: 10.1111/Bph.13528 |
0.606 |
|
| 2016 |
Wilkerson JL, Ghosh S, Bagdas D, Mason BL, Crowe MS, Hsu KL, Wise LE, Kinsey SG, Damaj MI, Cravatt BF, Lichtman AH. Diacylglycerol lipase beta inhibition reverses nociceptive behavior in mouse models of inflammatory and neuropathic pain. British Journal of Pharmacology. PMID 26915789 DOI: 10.1111/Bph.13469 |
0.766 |
|
| 2016 |
Wilkerson JL, Niphakis MJ, Grim TW, Mustafa MA, Abdullah RA, Poklis JL, Dewey WL, Akbarali HI, Banks ML, Wise LE, Cravatt BF, Lichtman AH. The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model. The Journal of Pharmacology and Experimental Therapeutics. PMID 26791602 DOI: 10.1124/Jpet.115.229971 |
0.75 |
|
| 2015 |
Mukhopadhyay P, Baggelaar M, Erdelyi K, Cao Z, Cinar R, Fezza F, Ignatowska-Jankowska B, Wilkerson J, van Gils N, Hansen T, Ruben M, Soethoudt M, Heitman L, Kunos G, Maccarrone M, et al. The novel, orally available and peripherally restricted selective cannabinoid CB2 -receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. British Journal of Pharmacology. PMID 26398481 DOI: 10.1111/Bph.13338 |
0.747 |
|
| 2015 |
Ignatowska-Jankowska B, Wilkerson JL, Mustafa M, Abdullah R, Niphakis M, Wiley JL, Cravatt BF, Lichtman AH. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice. The Journal of Pharmacology and Experimental Therapeutics. 353: 424-32. PMID 25762694 DOI: 10.1124/Jpet.114.222315 |
0.757 |
|
| 2014 |
Dengler EC, Alberti LA, Bowman BN, Kerwin AA, Wilkerson JL, Moezzi DR, Limanovich E, Wallace JA, Milligan ED. Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain. Journal of Neuroinflammation. 11: 92. PMID 24884664 DOI: 10.1186/1742-2094-11-92 |
0.773 |
|
| 2013 |
Dengler EC, Liu J, Kerwin A, Torres S, Olcott CM, Bowman BN, Armijo L, Gentry K, Wilkerson J, Wallace J, Jiang X, Carnes EC, Brinker CJ, Milligan ED. Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 209-24. PMID 23517784 DOI: 10.1016/J.Jconrel.2013.03.009 |
0.772 |
|
| 2012 |
Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Kuhn MN, Zvonok AM, Thakur GA, Makriyannis A, Milligan ED. Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia. Brain and Behavior. 2: 155-77. PMID 22574283 DOI: 10.1002/Brb3.44 |
0.792 |
|
| 2012 |
Wilkerson JL, Gentry KR, Dengler EC, Wallace JA, Kerwin AA, Armijo LM, Kuhn MN, Thakur GA, Makriyannis A, Milligan ED. Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels. Pain. 153: 1091-106. PMID 22425445 DOI: 10.1016/J.Pain.2012.02.015 |
0.794 |
|
| 2012 |
Wilkerson J, Alberti L, Wallace J, Kerwin A, Dengler E, Bowman B, Platero P, Thakur G, Makriyannis A, Ledent C, Milligan E. Selective cannabinoid receptor 2 (CB2R) agonist AM1710 acts independently of cannabinoid receptor 1 (CB1R) responses in neuropathic CB1R -/- mice The Journal of Pain. 13: S47. DOI: 10.1016/J.Jpain.2012.01.196 |
0.745 |
|
| 2011 |
Wilkerson JL, Milligan ED. The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief. Isrn Anesthesiology. 2011. PMID 22442754 DOI: 10.5402/2011/593894 |
0.697 |
|
| 2010 |
Brownjohn P, Milligan E, Wilkerson J, Ashton J. 162 IMMUNOHISTOCHEMICAL ANALYSIS OF CB2 RECEPTOR PROTEIN IN THE SPINAL CORD OF NEUROPATHIC RATS TREATED WITH THE CB2-SELECTIVE AGONIST GW405833 European Journal of Pain Supplements. 4: 48-49. DOI: 10.1016/S1754-3207(10)70167-X |
0.666 |
|
| 2010 |
Gentry KR, Wallace JA, Dengler EC, Wilkerson JL, Candelaria GA, Norenberg JP, Milligan ED. Macrophage recruitment to the spinal cord following intrathecal injection: A mechanism to enhance gene therapy as a treatment of neuropathic pain Journal of Critical Care. 25: e17-e18. DOI: 10.1016/J.Jcrc.2010.08.022 |
0.781 |
|
| 2009 |
Ashton J, Brownjohn P, Wilkerson J, Dowie M, Glass M, Milligan E. 166 INTRATHECAL INJECTION OF A CANNABINOID CB2 RECEPTOR SELECTIVE AGONIST GW405833 BLOCKS INDUCTION OF ALLODYNIA BY SCIATIC INFLAMMATORY NEURITIS (SIN) European Journal of Pain. 13. DOI: 10.1016/S1090-3801(09)60169-5 |
0.64 |
|
| 2009 |
Wilkerson J, Dengler E, Thakur G, Wallace J, Zvonok A, Makriyannis A, Ashton J, Milligan E. Administration of AM 1241, a cannabinoid 2 (CB2) receptor selective agonist, to the rodent spinal cord reverses Chronic Constriction Injury (CCI) induced allodynia The Journal of Pain. 10: S22. DOI: 10.1016/J.Jpain.2009.01.095 |
0.776 |
|
| Show low-probability matches. |